Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Evan T, Hall"'
Autor:
Evan T. Hall, John A. Thompson, Nathaniel F. Watson, Arthur Sillah, Joshua R. Veatch, Timothy A. Thornton, Scott S. Tykodi, Rachel C. Malen, Ulrike Peters, Amanda I. Phipps, Sylvia Lee, Jeannie Warner, Shailender Bhatia, Allison Silverman
Publikováno v:
Supportive Care in Cancer
Background: Sleep problems (SP) are common in cancer patients but have not been previously assessed in patients receiving immune checkpoint inhibitors (ICI).Methods: We collected questionnaire data on sleep apnea risk, insomnia and general sleep patt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fceecc2b401a56f73f7be907e72caf8
https://doi.org/10.1007/s00520-022-06825-w
https://doi.org/10.1007/s00520-022-06825-w
Autor:
Andrew J, Portuguese, Jordan, Gauthier, Scott S, Tykodi, Evan T, Hall, Alexandre V, Hirayama, Cecilia C S, Yeung, Christopher D, Blosser
Publikováno v:
Bone marrow transplantation.
Post-transplant lymphoproliferative disorder (PTLD) is a leading cause of cancer death in solid organ transplant recipients (SOTRs). Relapsed or refractory (R/R) PTLD portends a high risk of death and effective management is not well established. CD1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4d245f9118ffb3de12d1775d1843f4b0
https://pubmed.ncbi.nlm.nih.gov/36575360
https://pubmed.ncbi.nlm.nih.gov/36575360
Autor:
Xiaoyi Zheng, Fariborz Soroush, Jin Long, Evan T Hall, Puneeth K Adishesha, Sanchita Bhattacharya, Mohammad F Kiani, Vivek Bhalla
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0185250 (2017)
Diabetic nephropathy (DN) is the leading cause of kidney disease; however, there are no early biomarkers and no cure. Thus, there is a large unmet need to predict which individuals will develop nephropathy and to understand the molecular mechanisms t
Externí odkaz:
https://doaj.org/article/12f64a90f16e43c4ad6965dd57d96bd2
Autor:
Mollie F Qian, Nicolas J Betancourt, Alain Pineda, Nolan J Maloney, Kevin A Nguyen, Sunil A Reddy, Evan T Hall, Susan M Swetter, Lisa C Zaba
Publikováno v:
The oncologist.
Background Widespread implementation of immune checkpoint inhibitors (ICI) and targeted therapies for metastatic melanoma has led to a decline in melanoma-related mortality but increased healthcare costs. We aimed to determine how healthcare utilizat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42c14ff825c15c55e1ec83648c7c207c
https://pubmed.ncbi.nlm.nih.gov/36302223
https://pubmed.ncbi.nlm.nih.gov/36302223
Autor:
Arthur Sillah, Shailender Bhatia, Nathaniel F. Watson, Jeannie Warner, Allison Silverman, Evan T. Hall, Scott S. Tykodi, Amanda I. Phipps, Ulrike Peters, Rachel C. Malen, John A. Thompson, Joshua R. Veatch, Sylvia Lee
Publikováno v:
Future Oncology. 17:363-369
Lifestyle factors could plausibly modulate the host immune system, the tumor microenvironment and, hence, immune checkpoint inhibitor (ICI) response. As such, these factors should be considered in ICI studies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8a6ebef5a090055e589d153d45adee9
https://doi.org/10.2217/fon-2020-0730
https://doi.org/10.2217/fon-2020-0730
Autor:
Evan E. Gross, Mingjia Li, Ming Yin, Delaney Orcutt, Duncan Hussey, Elliot Trott, Sarah K. Holt, Erin R. Dwyer, Joel Kramer, Kaylee Oliva, John L. Gore, George R. Schade, Daniel W. Lin, Scott S. Tykodi, Evan T. Hall, John A. Thompson, Anish Parikh, Yuanquan Yang, Katharine A. Collier, Abdul Miah, Sherry Mori-Vogt, Megan Hinkley, Amir Mortazavi, Paul Monk, Edmund Folefac, Steven K. Clinton, Sarah P. Psutka
Publikováno v:
Urologic oncology. 41(1)
Cytoreductive nephrectomy (CN) for the treatment of metastatic renal cell carcinoma (mRCC) was called into question following the publication of the CARMENA trial. While previous retrospective studies have supported CN alongside targeted therapies, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2100a947c4098343385cd0ea3362d1a2
https://pubmed.ncbi.nlm.nih.gov/36441070
https://pubmed.ncbi.nlm.nih.gov/36441070
Autor:
Touran Fardeen, Ranak B. Trivedi, Lidia Schapira, Caroline Gray, Surbhi Singhal, Deepa Sridhar, Evan T. Hall, Sheila Lahijani
Publikováno v:
Supportive Care in Cancer. 29:2493-2500
Patients with cancer spend significant time receiving treatment and recovering from side effects. Little is known about how patients and their caregivers perceive time spent receiving cancer treatment and how this impacts health-related quality of li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a115f4ee66419fcb5a38eed78a3e4b23
https://doi.org/10.1007/s00520-020-05763-9
https://doi.org/10.1007/s00520-020-05763-9
Publikováno v:
American Society of Clinical Oncology Educational Book. :398-407
In this review, we summarize the immunology of nonmelanoma skin cancers (NMSCs) and the clinical data with immunotherapy in this heterogeneous group of cancers that include basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (CSCC), and Mer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4602606e42b11bd1234f5a310dd3d1ee
https://doi.org/10.1200/edbk_278953
https://doi.org/10.1200/edbk_278953
Autor:
Sukhmani K. Padda, Touran Fardeen, George A. Fisher, Tyler Johnson, Gilbert Chu, Bianca Bruzzone, Brianna Velazquez, Gregory M. Heestand, Olga Generalova, Sigurdis Haraldsdottir, Sandy Srinivas, Kristen M. Cunanan, Mohana Roy, Robert W. Hsieh, Joel W. Neal, Heather A. Wakelee, Sumit A. Shah, Evan T. Hall, Anna Cabot, Kavitha Ramchandran, Alice C. Fan
Publikováno v:
Journal of Patient-Reported Outcomes
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-11 (2021)
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-11 (2021)
Background Patient reported outcomes (PROs) have been associated with improved symptom management and quality of life in patients with cancer. However, the implementation of PROs in an academic clinical practice has not been thoroughly described. Her
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04fbeeda8067be554d051f708c25d6c3
https://doi.org/10.1186/s41687-021-00358-2
https://doi.org/10.1186/s41687-021-00358-2
Autor:
Steven K. Clinton, Amir Mortazavi, Abdul Miah, Evan Gross, Edmund Folefac, Evan T. Hall, Katharine Collier, Kaylee Oliva, Paul Monk, Megan Hinkley, Yuanquan Yang, John F. Thompson, John C. Gore, Delaney Orcutt, Joel Kramer, Duncan Hussey, Mingjia Li, Sherry Mori-Vogt, George R. Schade, Scott S. Tykodi, Sarah P. Psutka, Anish B. Parikh, Elliot Trott, Ming Yin, Daniel W. Lin
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:The role of CN in the treatment of mRCC has been questioned with the recent approval of novel systemic therapy (ST) agents and the results of the CARMENA trial. Our objec...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::885ea6ab2796cd6eeb1eba01afdbabd7
https://doi.org/10.1097/ju.0000000000001995.08
https://doi.org/10.1097/ju.0000000000001995.08